CHRDL1 and neoplasm: Furthermore, multivariate analysis suggested that CHRDL1 was independently correlative with OS (Table 3), with a HR of 0.563(P=0.016), along with primary therapy outcome (HR=2.022, P=0.002) and tumor status (HR=5.956, P<0.001).